我要投票 片仔癀药业在医疗保健行业中的票数:413
· 外 推 电 报 ·
2025-08-05 09:01:00 星期二

【片仔癀药业是哪个国家的品牌?】

片仔癀药业是什么牌子?「片仔癀药业」是 漳州片仔癀药业股份有限公司 旗下著名品牌。该品牌发源于福建,由创始人刘建顺在1555期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力片仔癀药业品牌出海!将品牌入驻外推网,定制片仔癀药业品牌推广信息,可以显著提高片仔癀药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

漳州片仔癀药业股份有限公司,是漳州市制药厂改制创立的,是全国“重合同、守信用”企业、国家火炬高新技术企业、福建省百家重点工业企业、居我国中成药行业50强。公司连续多年入选福建省工业主要行业竞争力十强、工业300强、工业效益300强、利税300强。公司以生产名贵中成药——片仔癀而享誉海内外,注册的“片仔癀”商标于1999年元月被评为“中国驰名商标”,2006年入选商务部首批“中华老字号”、并入选中华老字号品牌价值百强榜20强,福建省出口名牌,片仔癀系列产品首批通过国家原产地标记认证,并被评为福建省名牌产品。2002年经国家人事部批准,设立博士后科研工作站。公司股票于2003年6月16日在上海证券交易所成功上市,2003年度列全国1200多家上市公司综合绩效排名第11位,2004年被评为福建省大、中型国有及国有控股企业效绩“十佳”。

公司的主导产品——片仔癀,两度荣获国家质量金质奖,并被列入国家中药一级保护品种,其以独特的消炎、解毒、镇痛、保肝等显著疗效及保护健康的功能而深受国内外患者的赞誉,被誉为“国宝神药”,并大量出口东南亚、日本、韩国、加拿大等国家和地区,年出口创汇超千万美元,居中国中成药单项出口创汇首位。2000年片仔癀作为内地第一个获得香港政府创新及科技基金无偿资助的中成药研究项目,由香港中文大学进行片仔癀保肝作用研究。

公司视产品质量为企业的生命,严格按国家GMP规范要求组织生产。公司始终重视新药的研发和老产品二次开发工作。近年来,相继研制开发投产了包括金糖宁胶囊、心舒宝片、清热止咳颗粒、复方片仔癀含片、增乳膏等在内的十几个新产品,使公司每年都有新产品面市,老产品二次开发--片仔癀胶囊增加适应症的临床研究被国家列入“863”计划。

目前公司有如下几个系列产品:

1.片仔癀系列:片仔癀、片仔癀胶囊、复方片仔癀软膏、复方片仔癀痔疮软膏、复方片仔癀含片;

2.感冒止咳系列:清热止咳颗粒、川贝清肺糖浆、藿香正气水(胶囊)、金牡感冒片、小柴胡颗粒、板蓝根颗粒、小儿止咳糖浆等;

3.丸剂系列:六味地黄丸、杞菊地黄丸、知柏地黄丸、香砂六君丸、逍遥丸;

4.保肝护肝类:茵胆平肝胶囊、护肝片;

5.妇女儿童类:增乳膏、逍遥丸、小儿止咳糖浆;

6.心血管类:心舒宝片、复方丹参片;

7.其它:少林正骨精、牛黄解毒片、蜂乳胶囊、金糖宁胶囊等等;

8.另外还有仅供国外销售产品:龙江牌特效片仔癀暗疮膏、复方片仔癀肝宝、片仔癀活络油、片仔癀白花蛇解痒片、片仔癀润喉片、片仔癀消炎胶囊、片仔癀润喉糖、片仔癀跌打精等。

英文翻译:Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. was founded by Zhangzhou pharmaceutical factory. It is a national "contract and credit" enterprise, a national torch high-tech enterprise, a hundred key industrial enterprises in Fujian Province, and one of the top 50 Chinese patent medicine enterprises in China. For many years, the company has been selected as one of the top ten industrial competitiveness, top 300 industry, top 300 industrial efficiency and top 300 profit and tax. The company is famous at home and abroad for the production of famous Chinese patent medicine - pianzehuang. The registered "pianzehuang" trademark was rated as "China's famous trademark" in January 1999. In 2006, it was selected as the first batch of "China's time-honored brand" by the Ministry of Commerce, and was listed as the top 20 in the top 100 brand value list of China's time-honored brand. Fujian Province's export famous brand, pianzehuang series of products passed the national origin mark certification in the first batch, and was evaluated It is a famous brand product in Fujian Province. In 2002, with the approval of the Ministry of personnel of the people's Republic of China, a postdoctoral research station was established. The company's shares were successfully listed on the Shanghai Stock Exchange on June 16, 2003. In 2003, it ranked 11th in the comprehensive performance of more than 1200 listed companies in China. In 2004, it was rated as the "top ten" performance of large, medium-sized state-owned and state-owned holding enterprises in Fujian Province. The company's leading product, pianzehuang, has twice won the national quality gold medal and has been listed in the first level national protection of traditional Chinese medicine. It is highly praised by patients at home and abroad for its unique anti-inflammatory, detoxification, analgesic, liver protection and other remarkable curative effects and health protection functions. It is known as the "national treasure drug" and exported to Southeast Asia, Japan, South Korea, Canada and other countries and regions, The annual export earnings exceed ten million US dollars, ranking first in the single export earnings of Chinese patent medicine. In 2000, as the first Chinese patent medicine research project funded by the Hong Kong government innovation and science and technology fund, the Chinese University of Hong Kong carried out the research on the liver protection effect of Pianzihuang. The company regards product quality as the life of the enterprise and organizes production in strict accordance with the requirements of GMP. The company always attaches great importance to the research and development of new drugs and the secondary development of old products. In recent years, more than ten new products including Jintangning capsule, Xinshubao tablet, Qingre Zhike granules, compound Pianzihuang buccal tablet, Zengyao and so on have been developed and put into production successively, which makes the company have new products on the market every year. The second development of old products -- clinical research on the indication of increasing Pianzihuang capsule has been listed in the "863" plan by the state. At present, the company has the following series of products: 1. Pianzihuang series: Pianzihuang, Pianzihuang capsule, compound Pianzihuang ointment, compound Pianzihuang hemorrhoids ointment, compound Pianzihuang buccal tablet; 2. Cold and cough series: Qingre Zhike granules, Chuanbei Qingfei syrup, Huoxiang Zhengqi water (capsule), Jinmu cold tablet, Xiaochaihu granules, Banlangen Granules, Xiaoer Zhike syrup, etc.; 3. Pills Series: Liuwei Dihuang pill, Qiju Dihuang pill, Zhibai Dihuang pill, Xiangsha Liujun pill, Xiaoyao Pill; 4. Liver protection and liver protection: yindanpinggan capsule, Hugan tablet; 5. Women and children: Zengyao, Xiaoyao Pill, Xiaoer cough syrup; 6. Cardiovascular: Xinshubao tablet, Fufang Danshen tablet; 7. Others: Shaolin zhenggujing, Niuhuang Jiedu tablet, bee milk capsule, Jintangning capsule, etc.; 8 In addition, there are only foreign products for sale: Longjiang brand special effect pianzehuang acne cream, compound pianzehuang Ganbao, pianzehuang Huoluo oil, pianzehuang Baihua snake antipruritic tablet, pianzehuang Runhou tablet, pianzehuang Xiaoyan capsule, pianzehuang Runhou sugar, pianzehuang drop hit essence, etc.

本文链接: https://www.waitui.com/brand/5a0277eda.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

改革加速,多家农信社省级机构招兵买马

截至目前,河南、内蒙古等地的农村信用社省级机构已挂牌营业,国内由农信改革而生的新省级机构达到了10家。改革发展向来离不开人才。近期,浙江、辽宁、海南、江西等地的多家农村信用社省级机构均发布了社会招聘公告,招纳总行高管、金融科技、公司金融等相关人才。业内人士指出,各地农村信用社省级机构陆续筹备落地,经营状态也将从“挂牌运营”走向“完善治理”,相应的人才队伍特别是金融科技人才急需补充和储备,以来提升差异化服务、数字化风控等能力,预计未来市场化招聘高管也将成为新趋势。(证券时报)

2小时前

国债等债券利息收入8日起恢复征收增值税,机构称对券商业绩影响较小

根据日前财政部、国家税务总局发布的《关于国债等债券利息收入增值税政策的公告》,自2025年8月8日起,对在该日期之后(含当日)新发行的国债、地方政府债券、金融债券的利息收入,恢复征收增值税。在机构人士看来,增值税采用“新老划段”方式恢复征收,对于券商自营业务的影响可控,要关注券商自营业务配置的股债再平衡趋势,以及券商板块业绩和估值修复。(中证网)

2小时前

人形机器人“订单潮”涌动,表演、导览仍是“主战场”

近期多位头部选手不约而同地斩获了大单,前有智元机器人、宇树科技“分食”总预算1.24亿元的人形双足机器人代工服务采购项目,后有优必选中标总预算9051.15万元的机器人设备采购项目。总体上看,上述订单的主要应用场景为表演讲解、展馆导览等交互服务领域。业内认为,从高关注度、低技术门槛的表演导览场景切入,是新技术推广的普遍规律和务实选择,也是后续拓展至工业制造及家庭服务场景的必要基础和起点。当前人形机器人产业所展现的“订单潮”,正是这条漫长产业征途上落下的一串脚印。(上证报)

2小时前

华泰证券:看好价值重估逻辑下的商业地产板块

36氪获悉,华泰证券研报表示看好价值重估逻辑下的商业地产板块:头部运营商购物中心资产均超越账面投资性房地产公允价值,而更为关键的是,C-REITs通道使得这一价值的实现路径更为通畅,流动性增厚使得这一估值更具有参考意义。在商业地产着重布局的开发类企业以及具备运营管理溢价的物管标的都面临发展机遇。

2小时前

A股半年报前瞻:高比例分红成亮点

A股半年报陆续披露。Wind数据显示,截至8月4日18时,A股共有87家上市公司对外披露2025年半年报,其中58家上市公司实现归属于上市公司股东的净利润同比增长。从利润分配角度看,目前,已有30家上市公司发布半年报的同时,对外发布2025年半年度利润分配预案,不少公司拟派发现金红利比例较高。(中证报)

2小时前

本页详细列出关于片仔癀药业的品牌信息,含品牌所属公司介绍,片仔癀药业所处行业的品牌地位及优势。
咨询